Keyphrases
Candida Albicans (C. albicans)
100%
Myeloproliferative Neoplasms
90%
Juvenile Myelomonocytic Leukemia
86%
GTPase-activating Protein
73%
Neurofibromin
73%
Ras Activation
66%
K-ras
66%
N-Ras
66%
Acute Myeloid Leukemia Cells
66%
Enterocyte
66%
C.albicans
66%
Mutant Mice
66%
Hematopoietic Disorders
66%
Glioma Cells
66%
CD133
66%
Stem Cells
56%
Hematopoietic Cells
53%
Glioma
51%
Tetracycline Transactivator
50%
Science Programmes
44%
Transgenic Mice
41%
Tetracycline
41%
Web-based
41%
Preceptor
41%
Tumor
41%
HT-29
40%
Mutant Strains
40%
Gene Loss
38%
Medical Laboratory Science
38%
Antibiotic-treated Mice
37%
Glioblastoma multiforme
37%
Antibiotics
36%
Clinical Experience
35%
Systemic Spread
33%
Paracellular Transmigration
33%
Epithelial Permeability
33%
Variable Phenotype
33%
P19Arf
33%
Intratumoral Heterogeneity
33%
Virtual Microscopy
33%
Glioma Cell Lines
33%
Plasmid DNA (pDNA)
33%
Acute Leukemia
33%
Filamentous Form
33%
Mast Cell Activation Syndrome
33%
Mast Cells
33%
Transgene Expression System
33%
Hemostasis
33%
Rational Treatment
33%
Scenario-based Training
33%
Medicine and Dentistry
Neoplasm
66%
Ganglioglioma
60%
Juvenile Myelomonocytic Leukemia
53%
Hematopoietic Stem Cell
46%
Transgene
40%
Myeloproliferative Disorder
38%
Health Care Cost
38%
Tetracycline
33%
Promoter Region
33%
Blood Stasis
33%
B Cell
33%
Myeloproliferative Neoplasm
33%
STAT5 Protein
33%
Gene Expression System
33%
T Cell
33%
Systemic Candidiasis
33%
Antibiotics
33%
Caco-2
33%
Receptor
33%
Medical Laboratory Technology
33%
Dexamethasone
33%
Glioma Cell Line
33%
Gene Product
33%
Glioma Cell
33%
Cancer Stem Cell
33%
Neurofibromatosis Type I
25%
Granulocyte Macrophage Colony Stimulating Factor Receptor
25%
Stem Cell
21%
Mesenteric Lymph Nodes
16%
High Resolution Scanning Electron Microscopy
16%
Enzyme Linked Immunosorbent Assay
16%
Intensive Care Unit
16%
Epithelial Cell
16%
Infectious Complication
16%
Antifungal Therapy
16%
Absence
16%
Janus Kinase
16%
Cancer
16%
Microvillus
16%
Intestinal Epithelium
16%
Glioblastoma
16%
Molecularly Targeted Therapy
16%
Disease
16%
Side Population
13%
Granulocyte Macrophage Colony Stimulating Factor
12%
Luciferase
11%
Hematopoietic Stem Cell
11%
Doxycycline
9%
Mastocytosis
9%
Infection
8%
